10-Year Follow-Up: Pembrolizumab Outshines Ipilimumab in Advanced Melanoma
Long-term study shows pembrolizumab's superior efficacy over ipilimumab for advanced melanoma patients.
Small Cell Lung Cancer
1 article
Antibiotics, PPIs, and Probiotics: No Impact on Immunotherapy Outcomes in ES-SCLC
Study finds common medications don't affect immunotherapy efficacy in extensive-stage small cell lung cancer.